These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9292911)

  • 1. Implications of early inflammation and infection in cystic fibrosis: a review of new and potential interventions.
    Weller PH
    Pediatr Pulmonol; 1997 Aug; 24(2):143-5; discussion 159-61. PubMed ID: 9292911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model of mucociliary clearance in cystic fibrosis lungs.
    Kurbatova P; Bessonov N; Volpert V; Tiddens HA; Cornu C; Nony P; Caudri D;
    J Theor Biol; 2015 May; 372():81-8. PubMed ID: 25746843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unplugging Mucus in Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.
    Mall MA
    Ann Am Thorac Soc; 2016 Apr; 13 Suppl 2():S177-85. PubMed ID: 27115954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dornase alfa on inflammation and lung function: potential role in the early treatment of cystic fibrosis.
    Konstan MW; Ratjen F
    J Cyst Fibros; 2012 Mar; 11(2):78-83. PubMed ID: 22093951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled mannitol for cystic fibrosis.
    Nolan SJ; Thornton J; Murray CS; Dwyer T
    Cochrane Database Syst Rev; 2015 Oct; (10):CD008649. PubMed ID: 26451533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled medications in cystic fibrosis beyond antibiotics.
    Sepe A; Villella VR; Cimbalo C; Castaldo A; Nunziata F; Corcione A; Bona G; Maiuri L; Raia V
    Minerva Pediatr; 2019 Aug; 71(4):371-375. PubMed ID: 30761821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Timing of dornase alfa inhalation for cystic fibrosis.
    Dentice R; Elkins M
    Cochrane Database Syst Rev; 2011 May; (5):CD007923. PubMed ID: 21563162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Rhinosinusitis in Patients with Cystic Fibrosis.
    Hamilos DL
    J Allergy Clin Immunol Pract; 2016; 4(4):605-12. PubMed ID: 27393775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapies aimed at airway inflammation in cystic fibrosis.
    Konstan MW
    Clin Chest Med; 1998 Sep; 19(3):505-13, vi. PubMed ID: 9759552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertonic saline for cystic fibrosis: worth its salt?
    Goralski JL; Donaldson SH
    Expert Rev Respir Med; 2014 Jun; 8(3):267-9. PubMed ID: 24666113
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of uridine 5'-triphosphate plus amiloride on mucociliary clearance in adult cystic fibrosis.
    Bennett WD; Olivier KN; Zeman KL; Hohneker KW; Boucher RC; Knowles MR
    Am J Respir Crit Care Med; 1996 Jun; 153(6 Pt 1):1796-801. PubMed ID: 8665037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucus obstruction and inflammation in early cystic fibrosis lung disease: Emerging role of the IL-1 signaling pathway.
    Balázs A; Mall MA
    Pediatr Pulmonol; 2019 Nov; 54 Suppl 3():S5-S12. PubMed ID: 31715090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and adverse effects of drugs used to treat adult cystic fibrosis.
    Chopra R; Paul L; Manickam R; Aronow WS; Maguire GP
    Expert Opin Drug Saf; 2015 Mar; 14(3):401-11. PubMed ID: 25604518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of smaller droplet size of dornase alfa on lung function in mild cystic fibrosis. Dornase Alfa Nebulizer Group.
    Geller DE; Eigen H; Fiel SB; Clark A; Lamarre AP; Johnson CA; Konstan MW
    Pediatr Pulmonol; 1998 Feb; 25(2):83-7. PubMed ID: 9516090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dornase alfa for cystic fibrosis.
    Jones AP; Wallis C
    Cochrane Database Syst Rev; 2010 Mar; (3):CD001127. PubMed ID: 20238314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aerosolized dornase alfa (rhDNase) for therapy of cystic fibrosis.
    Hodson ME
    Am J Respir Crit Care Med; 1995 Mar; 151(3 Pt 2):S70-4. PubMed ID: 7881698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aerosolized dornase alfa in cystic fibrosis: is there a role in the management of patients with early obstructive lung disease?
    Geller DE
    Pediatr Pulmonol; 1997 Aug; 24(2):155-8; discussion 159-61. PubMed ID: 9292913
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical presentations of pulmonary aspergillosis in children with cystic fibrosis - preliminary report.
    Walicka-Serzysko K; Sands D
    Dev Period Med; 2015; 19(1):66-79. PubMed ID: 26003072
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucolytics in cystic fibrosis.
    Henke MO; Ratjen F
    Paediatr Respir Rev; 2007 Mar; 8(1):24-9. PubMed ID: 17419975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New and emerging therapies for pulmonary complications of cystic fibrosis.
    Tonelli MR; Aitken ML
    Drugs; 2001; 61(10):1379-85. PubMed ID: 11558827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.